This Is What Whales Are Betting On Pfizer
Portfolio Pulse from Benzinga Insights
A large investor has taken a bullish stance on Pfizer (NYSE:PFE), with 22 uncommon options trades spotted for the company. The sentiment of these big-money traders is split between 77% bullish and 22% bearish. The whales have been targeting a price range from $35.0 to $43.0 for Pfizer over the last 3 months. BMO Capital and Morgan Stanley have maintained their Outperform and Equal-Weight ratings on Pfizer respectively, with price targets of $44 and $42.
August 18, 2023 | 8:45 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
A large investor has taken a bullish stance on Pfizer, indicating potential positive movement in the short term. Analysts from BMO Capital and Morgan Stanley have maintained positive ratings on the company.
The bullish stance taken by a large investor, along with the positive ratings maintained by analysts, indicate potential positive movement for Pfizer's stock in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100